{
    "paper_id": "PMC7110781",
    "metadata": {
        "title": "Agents infectieux \u00e9mergents",
        "authors": [
            {
                "first": "C.",
                "middle": [],
                "last": "Chidiac",
                "suffix": "",
                "email": "christian.chidiac@chu-lyon.fr",
                "affiliation": {}
            },
            {
                "first": "T.",
                "middle": [],
                "last": "Ferry",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "En 1967, William Stewart, surgeon g\u00e9n\u00e9ral des \u00c9tats-Unis aurait d\u00e9clar\u00e9 la \u00ab fin de la guerre contre la pestilence et la fermeture du grand livre des maladies infectieuses \u00bb ; dans le m\u00eame temps, se propageait l\u2019\u00e9pid\u00e9mie de sida [1]. Depuis, de nombreux autres pathog\u00e8nes ont \u00e9merg\u00e9s, dont le VHC, le syndrome respiratoire aigu s\u00e9v\u00e8re (SRAS), l\u2019infection \u00e0 virus West Nile, le chikungunya, la grippe aviaire A(H5N1), le MERS-CoV, la grippe pand\u00e9mique A(H1N1)pdm2009, la maladie \u00e0 virus Ebola (MVE), l\u2019infection \u00e0 virus Zika\u2026",
            "cite_spans": [
                {
                    "start": 229,
                    "end": 232,
                    "mention": "[1]",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Selon la d\u00e9finition retenue par le HCSP, une maladie infectieuse \u00e9mergente (MIE) est une maladie infectieuse \u2013 ou pr\u00e9sum\u00e9e infectieuse \u2013 inattendue (en r\u00e9f\u00e9rence aux propri\u00e9t\u00e9s intrins\u00e8ques ou \u00e0 la connaissance que l\u2019on a de la biologie de son agent responsable), touchant l\u2019homme, l\u2019animal ou les deux [2]. Il peut s\u2019agir : (i) d\u2019une entit\u00e9 clinique d\u2019origine infectieuse nouvellement apparue ou identifi\u00e9e, ou (ii) d\u2019une maladie infectieuse connue, dont l\u2019incidence augmente ou dont les caract\u00e9ristiques (cliniques, \u00e9volutives\u2026) se modifient dans un espace ou dans un groupe de population donn\u00e9.",
            "cite_spans": [
                {
                    "start": 303,
                    "end": 306,
                    "mention": "[2]",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Le but de cette revue limit\u00e9e est de d\u00e9crire certaines maladies infectieuses \u00e9mergentes et les r\u00e9ponses apport\u00e9es. Cependant, l\u2019\u00e9volution permanente des connaissances, en particulier pour les \u00e9mergences, invite les lecteurs \u00e0 se reporter aux publications les plus r\u00e9centes post\u00e9rieures \u00e0 cette revue non exhaustive.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Une transmission du germe de personne \u00e0 personne par contact rapproch\u00e9 a \u00e9t\u00e9 suspect\u00e9e en raison du nombre \u00e9lev\u00e9 de cas parmi les personnels soignants [6] et les modalit\u00e9s de transmission d\u00e9crites ont celles d\u2019une transmission par les s\u00e9cr\u00e9tions, puis envisag\u00e9e par a\u00e9rosol. La transmission principalement a\u00e9rienne du virus coupl\u00e9e \u00e0 des voyages de plus en plus nombreux ont permis la propagation du virus [7]. L\u2019\u00e9valuation du risque a \u00e9t\u00e9 faite rapidement sur la gravit\u00e9 des cas, la diffusion rapide et l\u2019atteinte plus particuli\u00e8re des personnels soignants [8], [9].",
            "cite_spans": [
                {
                    "start": 151,
                    "end": 154,
                    "mention": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 406,
                    "end": 409,
                    "mention": "[7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 558,
                    "end": 561,
                    "mention": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 563,
                    "end": 566,
                    "mention": "[9]",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Transmission ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "L\u2019existence de formes cliniques paucisymptomatiques, voire asymptomatiques, de SRAS est possible (Tableau 1, Tableau 2\n). Les signes cliniques d\u00e9butent le plus souvent apr\u00e8s une p\u00e9riode d\u2019incubation de 2 \u00e0 11 jours (6 jours en moyenne). Le tableau comporte les \u00e9l\u00e9ments suivants : fi\u00e8vre (94 \u00e0 100 % des cas), syndrome pseudo-grippal (28 \u00e0 74 %), signes respiratoires (50 \u00e0 69 %), signes digestifs (10 \u00e0 27 %).",
            "cite_spans": [],
            "section": "Pr\u00e9sentation clinique et biologique ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": [
                {
                    "start": 98,
                    "end": 107,
                    "mention": "Tableau 1",
                    "ref_id": "TABREF0"
                },
                {
                    "start": 109,
                    "end": 118,
                    "mention": "Tableau 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "\u00c0 la phase pr\u00e9coce, l\u2019examen physique est souvent pauvre, avec parfois une auscultation pulmonaire anormale. L\u2019\u00e9volution est marqu\u00e9e par le risque de d\u00e9tresse respiratoire au cours de la deuxi\u00e8me semaine, avec 25 % de s\u00e9jour en r\u00e9animation et environ 10 % de mortalit\u00e9 surtout fonction des comorbidit\u00e9s [10], [11].",
            "cite_spans": [
                {
                    "start": 303,
                    "end": 307,
                    "mention": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 309,
                    "end": 313,
                    "mention": "[11]",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "Pr\u00e9sentation clinique et biologique ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "Le diagnostic de SRAS repose d\u2019abord sur le contexte \u00e9pid\u00e9miologique.",
            "cite_spans": [],
            "section": "Diagnostic ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "La biologie sanguine non sp\u00e9cifique peut r\u00e9v\u00e9ler l\u2019existence d\u2019une lymphop\u00e9nie, d\u2019une thrombop\u00e9nie, d\u2019une \u00e9l\u00e9vation des transaminases, d\u2019une augmentation des LDH et de la CPK.",
            "cite_spans": [],
            "section": "Diagnostic ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "La radiographie pulmonaire peut \u00eatre normale initialement. Les anomalies sont \u00e0 pr\u00e9dominance interstitielle, focalis\u00e9es ou diffuses.",
            "cite_spans": [],
            "section": "Diagnostic ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "Le diagnostic de certitude repose sur l\u2019identification du virus dans les s\u00e9cr\u00e9tions respiratoires ou dans les selles ou sur la s\u00e9rologie, le meilleur examen \u00e9tant la d\u00e9tection par RT-PCR [11].",
            "cite_spans": [
                {
                    "start": 187,
                    "end": 191,
                    "mention": "[11]",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "Diagnostic ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "Les autres \u00e9tiologies de pneumopathie doivent \u00eatre syst\u00e9matiquement \u00e9limin\u00e9es.",
            "cite_spans": [],
            "section": "Diagnostic ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "Les mesures ayant permis le contr\u00f4le de la maladie sont :\u2022la d\u00e9tection pr\u00e9coce des cas suspects et probables ;\u2022les mesures strictes d\u2019isolement respiratoire des cas probables ;\u2022les mesures de protection du personnel soignant et d\u2019un isolement pendant 10 jours (quarantaine) des personnes ayant \u00e9t\u00e9 en contact avec des cas probables ;\u2022l\u2019information du public et recommandations quant \u00e0 la restriction de voyager dans les zones de transmission active du SRAS ;\u2022les mesures de contr\u00f4le aux fronti\u00e8res ;\u2022la mise en place d\u2019un syst\u00e8me d\u2019alerte et de surveillance national et international [2].\n",
            "cite_spans": [
                {
                    "start": 584,
                    "end": 587,
                    "mention": "[2]",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Contr\u00f4le ::: Syndrome respiratoire aigu s\u00e9v\u00e8re",
            "ref_spans": []
        },
        {
            "text": "Le virus de la grippe aviaire A(H5N1) peut se transmettre \u00e0 l\u2019homme lors de contacts fr\u00e9quents et intensifs avec des s\u00e9cr\u00e9tions respiratoires et des d\u00e9jections d\u2019animaux infect\u00e9s. Bien que quelques clusters de taille r\u00e9duite aient \u00e9t\u00e9 rapport\u00e9s, incluant des cas chez des soignants, les donn\u00e9es \u00e9pid\u00e9miologiques et virologiques sugg\u00e8rent que le virus n\u2019a pas acquis la comp\u00e9tence d\u2019une transmission inter humaine [13], [14].",
            "cite_spans": [
                {
                    "start": 413,
                    "end": 417,
                    "mention": "[13]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 419,
                    "end": 423,
                    "mention": "[14]",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Transmission ::: Grippe aviaire A(H5N1)",
            "ref_spans": []
        },
        {
            "text": "Les manifestations cliniques sont celles d\u2019une infection respiratoire aigu\u00eb s\u00e9v\u00e8re, d\u2019\u00e9volution souvent fatale. Les caract\u00e9ristiques d\u00e9crites \u00e0 partir de pr\u00e8s de 60 cas figurent au niveau du Tableau 3\n.",
            "cite_spans": [],
            "section": "Clinique ::: Grippe aviaire A(H5N1)",
            "ref_spans": [
                {
                    "start": 191,
                    "end": 200,
                    "mention": "Tableau 3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "Est consid\u00e9r\u00e9 comme cas possible selon l\u2019Invs [15] :\u2022toute personne qui a pr\u00e9sent\u00e9 des signes cliniques d\u2019infection respiratoire aigu\u00eb basse grave (n\u00e9cessitant une hospitalisation) sans autre \u00e9tiologie identifi\u00e9e pouvant expliquer la pathologie et qui, au cours des 10 jours avant le d\u00e9but de ses sympt\u00f4mes, a voyag\u00e9 ou s\u00e9journ\u00e9 dans les zones expos\u00e9es hors France ou a \u00e9t\u00e9 en contact rapproch\u00e9 et non prot\u00e9g\u00e9 avec des volailles (\u00e9levage, abattoir, gavage\u2026), plus particuli\u00e8rement plumes, d\u00e9jections, r\u00e9sidus des animaux lors des processus de nettoyage et d\u00e9sinfection, dans les d\u00e9partements fran\u00e7ais o\u00f9 le virus H5 hautement pathog\u00e8ne a \u00e9t\u00e9 d\u00e9tect\u00e9 ;\u2022toute personne co-expos\u00e9e, d\u00e9finie comme celle ayant s\u00e9journ\u00e9 dans les zones expos\u00e9es hors France avec le cas confirm\u00e9 ou celle ayant eu un contact rapproch\u00e9 et non prot\u00e9g\u00e9 avec les m\u00eame volailles en France que le cas confirm\u00e9, et qui dans les 10 jours suivant l\u2019exposition, pr\u00e9sente une infection respiratoire aigu\u00eb quelle que soit sa gravit\u00e9 ;\u2022tout contact \u00e9troit d\u2019un cas confirm\u00e9, qui pr\u00e9sente une infection respiratoire aigu\u00eb, quelle que soit sa gravit\u00e9, dans les 10 jours suivant le dernier contact avec le cas confirm\u00e9 pendant que ce dernier \u00e9tait malade (i.e. symptomatique).\n",
            "cite_spans": [
                {
                    "start": 46,
                    "end": 50,
                    "mention": "[15]",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Clinique ::: Grippe aviaire A(H5N1)",
            "ref_spans": []
        },
        {
            "text": "Le diagnostic biologique est r\u00e9serv\u00e9 \u00e0 des laboratoires sp\u00e9cialis\u00e9s dont les laboratoires de r\u00e9f\u00e9rence pour l\u2019Organisation mondiale de la sant\u00e9 (OMS) [13].",
            "cite_spans": [
                {
                    "start": 150,
                    "end": 154,
                    "mention": "[13]",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Diagnostic ::: Grippe aviaire A(H5N1)",
            "ref_spans": []
        },
        {
            "text": "La principale hypoth\u00e8se est celle d\u2019une transmission des chauves-souris aux cam\u00e9lid\u00e9s, lesquels constituent le principal r\u00e9servoir et la source de la transmission \u00e0 l\u2019homme. La consommation de produits d\u00e9riv\u00e9s des animaux (incluant viande et lait) crus ou insuffisamment cuits est \u00e0 risque de transmission [18].",
            "cite_spans": [
                {
                    "start": 306,
                    "end": 310,
                    "mention": "[18]",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Source du virus, transmission ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "De multiple foyers d\u2019infection \u00e0 MERS-CoV ont impliqu\u00e9 des \u00e9tablissements de sant\u00e9 [19], [20], [21], [22], [23], y compris en Cor\u00e9e du Sud [24] et plusieurs cas group\u00e9s nosocomiaux ont \u00e9t\u00e9 rapport\u00e9s. Parmi les 191 cas symptomatiques d\u2019infection \u00e0 MERS-CoV survenus \u00e0 Jeddah en Arabie Saoudite entre janvier et mai 2014, 40 (21 %) \u00e9taient des professionnels de sant\u00e9. Parmi 112/151 autres patients, un contact avec une structure sanitaire pour 98 d\u2019entre eux (87,5 %) a \u00e9t\u00e9 retrouv\u00e9e [25], [26].",
            "cite_spans": [
                {
                    "start": 83,
                    "end": 87,
                    "mention": "[19]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 89,
                    "end": 93,
                    "mention": "[20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 95,
                    "end": 99,
                    "mention": "[21]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 101,
                    "end": 105,
                    "mention": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 107,
                    "end": 111,
                    "mention": "[23]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 139,
                    "end": 143,
                    "mention": "[24]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 483,
                    "end": 487,
                    "mention": "[25]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 489,
                    "end": 493,
                    "mention": "[26]",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Source du virus, transmission ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "Les premi\u00e8res estimations du taux de reproduction (R0) du virus variaient de 0,6 (IC 95 % : [0,42\u20130,8]) \u00e0 0,69 [0,50\u20130,92]. D\u2019autres donn\u00e9es estiment le R0 \u00e0 0,5 [0,30\u20130,77], sugg\u00e9rant ainsi le faible potentiel \u00e9pid\u00e9mique du virus [27].",
            "cite_spans": [
                {
                    "start": 231,
                    "end": 235,
                    "mention": "[27]",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Source du virus, transmission ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "Le tableau clinique typique associe fi\u00e8vre, toux, dyspn\u00e9e (Tableau 4\n). La pneumonie est fr\u00e9quente mais non constante. Des signes digestifs, en particulier diarrh\u00e9e, ont \u00e9t\u00e9 rapport\u00e9s. La mortalit\u00e9 rapport\u00e9e est de l\u2019ordre 36 %. L\u2019existence de comorbidit\u00e9s, telles que le diab\u00e8te, l\u2019insuffisance r\u00e9nale, les maladies pulmonaires chroniques, les immunod\u00e9pressions sont des facteurs de risque de maladies s\u00e9v\u00e8res \u00e0 MERS-CoV [28], [29].",
            "cite_spans": [
                {
                    "start": 422,
                    "end": 426,
                    "mention": "[28]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 428,
                    "end": 432,
                    "mention": "[29]",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Clinique ::: MERS-CoV",
            "ref_spans": [
                {
                    "start": 59,
                    "end": 68,
                    "mention": "Tableau 4",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "Est consid\u00e9r\u00e9 comme cas possible toute personne ayant voyag\u00e9 ou s\u00e9journ\u00e9 dans un des pays list\u00e9s, qui, au cours des 14 jours apr\u00e8s son retour, a pr\u00e9sent\u00e9 : (i) des signes cliniques et/ou radiologiques de d\u00e9tresse respiratoire aigu\u00eb (SDRA) ou d\u2019infection du parenchyme pulmonaire, avec une fi\u00e8vre \u2265 38 \u00b0C et de la toux, sans autre \u00e9tiologie identifi\u00e9e pouvant expliquer la pathologie ; (ii) tout contact (ex. : famille, soignants) d\u2019un cas possible ou confirm\u00e9, ayant pr\u00e9sent\u00e9 une infection respiratoire aigu\u00eb quelle que soit sa gravit\u00e9, dans les 14 jours suivant le dernier contact avec le cas possible/confirm\u00e9 pendant que ce dernier \u00e9tait malade (i.e. symptomatique) ; (iii) toute personne ayant travaill\u00e9 ou ayant \u00e9t\u00e9 hospitalis\u00e9e dans un \u00e9tablissement hospitalier dans un des pays list\u00e9s et ayant pr\u00e9sent\u00e9 une infection respiratoire aigu\u00eb quelle que soit sa gravit\u00e9, dans les 14 jours suivant le dernier contact avec cet \u00e9tablissement ; (iv) toute personne ayant eu un contact proche avec un dromadaire ou un produit issu de l\u2019animal (lait non pasteuris\u00e9, viande crue, urine) dans un des pays list\u00e9s et ayant pr\u00e9sent\u00e9 une infection respiratoire aigu\u00eb, quelle que soit sa gravit\u00e9, dans les 14 jours suivant ce contact. Pour les personnes immunod\u00e9prim\u00e9es ou pr\u00e9sentant une pathologie chronique, il faut consid\u00e9rer \u00e9galement la survenue d\u2019un syndrome f\u00e9brile avec diarrh\u00e9e et/ou tableau clinique s\u00e9v\u00e8re [30].",
            "cite_spans": [
                {
                    "start": 1404,
                    "end": 1408,
                    "mention": "[30]",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Clinique ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "Le diagnostic repose sur l\u2019imagerie pulmonaire et la mise en \u00e9vidence du virus par RT-PCR. Seuls les pr\u00e9l\u00e8vements des voies a\u00e9riennes basses profonds sont formellement informatifs. Certains pr\u00e9l\u00e8vements trop pr\u00e9coces (moins de 4 jours apr\u00e8s l\u2019apparition des sympt\u00f4mes) peuvent \u00eatre faussement n\u00e9gatifs. L\u2019\u00e9volution clinique rapidement favorable des patients class\u00e9s cas possibles est un crit\u00e8re de jugement utile pour exclure une infection \u00e0 MERS-CoV.",
            "cite_spans": [],
            "section": "Diagnostic ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "D\u2019autres pr\u00e9l\u00e8vements sont possibles : selles (ou \u00e9couvillonnage rectal) en cas de diarrh\u00e9e, sanguins, en respectant strictement l\u2019application des mesures d\u2019hygi\u00e8ne de type contact (vir\u00e9mie d\u00e9montr\u00e9e chez certains patients) [29].",
            "cite_spans": [
                {
                    "start": 224,
                    "end": 228,
                    "mention": "[29]",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Diagnostic ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "Les mesures reposent sur la surveillance, la d\u00e9tection, le diagnostic, les mesures d\u2019isolement des cas suspects et possibles jusqu\u2019\u00e0 exclusion, et a fortiori des cas confirm\u00e9s, et des mesures locales vis-\u00e0-vis de la manipulation et la consommation d\u2019aliments d\u00e9riv\u00e9s des cam\u00e9lid\u00e9s, qui ne doivent pas \u00eatre exclus car nourrissants, mais bien cuits.",
            "cite_spans": [],
            "section": "Contr\u00f4le de la maladie ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "De mani\u00e8re importante, le risque de transmission nosocomiale souligne la n\u00e9cessit\u00e9 d\u2019observer les mesures de pr\u00e9vention et de lutte contre les infections respiratoires pour \u00e9viter la propagation du MERS-CoV dans les \u00e9tablissements de soins [29].",
            "cite_spans": [
                {
                    "start": 240,
                    "end": 244,
                    "mention": "[29]",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Contr\u00f4le de la maladie ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "Il n\u2019existe pas de vaccin ou de th\u00e9rapeutique sp\u00e9cifique.",
            "cite_spans": [],
            "section": "Contr\u00f4le de la maladie ::: MERS-CoV",
            "ref_spans": []
        },
        {
            "text": "La transmission vectorielle est r\u00e9alis\u00e9e par des moustiques, principalement A. aegypti et A. albopictus (transmission urbaine). Le moustique h\u00e9matophage s\u2019infecte lors d\u2019un repas sanguin et re-transmet le virus lors de repas sanguins ult\u00e9rieurs [32]. Une transmission autochtone chez 4 cas a \u00e9t\u00e9 d\u00e9crite r\u00e9cemment en Floride [33].",
            "cite_spans": [
                {
                    "start": 245,
                    "end": 249,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 325,
                    "end": 329,
                    "mention": "[33]",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "Transmission ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "Un premier cas de transmission sexuelle a \u00e9t\u00e9 d\u00e9crite aux \u00c9tats-Unis [34]. Depuis d\u2019autres cas ont confirm\u00e9 cette transmission, et une transmission de la femme \u00e0 l\u2019homme a \u00e9t\u00e9 d\u00e9crite r\u00e9cemment [35].",
            "cite_spans": [
                {
                    "start": 69,
                    "end": 73,
                    "mention": "[34]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 194,
                    "end": 198,
                    "mention": "[35]",
                    "ref_id": "BIBREF34"
                }
            ],
            "section": "Transmission ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "En 2016, 15 cas de transmission sexuelle ont \u00e9t\u00e9 rapport\u00e9s aux \u00c9tats-Unis et dans d\u2019autres pays [36]. Le plus long d\u00e9lai d\u00e9crit par rapport au d\u00e9but des sympt\u00f4mes atteint 32\u201341 jours [37]. L\u2019ARN du virus Zika a \u00e9t\u00e9 d\u00e9tect\u00e9 dans le sperme jusqu\u2019\u00e0 93 jours apr\u00e8s le d\u00e9but des sympt\u00f4mes [38] et plus r\u00e9cemment dans le fluide vaginal et la glaire cervicale 3 et 11 jours apr\u00e8s le d\u00e9but des sympt\u00f4mes respectivement [39], [40].",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 100,
                    "mention": "[36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 183,
                    "end": 187,
                    "mention": "[37]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 284,
                    "end": 288,
                    "mention": "[38]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 411,
                    "end": 415,
                    "mention": "[39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 417,
                    "end": 421,
                    "mention": "[40]",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "Transmission ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "Une transmission par transfusion sanguine, et p\u00e9rinatale par le lait maternel n\u2019a jamais \u00e9t\u00e9 mise en \u00e9vidence, mais le risque ne peut \u00eatre \u00e9cart\u00e9 [32], [41].",
            "cite_spans": [
                {
                    "start": 146,
                    "end": 150,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 152,
                    "end": 156,
                    "mention": "[41]",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "Transmission ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "Les sympt\u00f4mes (70 \u00e0 80 % asymptomatiques) non sp\u00e9cifiques se caract\u00e9risent par une \u00e9ruption cutan\u00e9e (exanth\u00e8me maculo-papuleux), \u00e9ventuellement accompagn\u00e9e de d\u00e9mangeaisons, avec ou sans fi\u00e8vre, et d\u2019autres sympt\u00f4mes tels que conjonctivite, fatigue, douleurs musculaires et articulaires, maux de t\u00eate et douleurs r\u00e9tro-orbitaires. Ces sympt\u00f4mes durent quelques jours et disparaissent spontan\u00e9ment. Le diagnostic de certitude est difficile, notamment lorsque coexistent dans la zone concern\u00e9e d\u2019autres arboviroses telles que la dengue ou le chikungunya.",
            "cite_spans": [],
            "section": "Manifestations cliniques ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "Deux types principaux de complications sont d\u00e9crits : des complications neurologiques, principalement des syndromes de Guillain-Barr\u00e9 et des complications embryof\u0153tales, notamment des microc\u00e9phalies (taille anormalement petite du cerveau) et des anomalies du d\u00e9veloppement c\u00e9r\u00e9bral intra-ut\u00e9rin. Le lien entre l\u2019infection et ces malformations est av\u00e9r\u00e9 [42].",
            "cite_spans": [
                {
                    "start": 353,
                    "end": 357,
                    "mention": "[42]",
                    "ref_id": "BIBREF41"
                }
            ],
            "section": "Manifestations cliniques ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "Il repose sur la mise en \u00e9vidence du g\u00e9nome (ARN) du virus dans le sang, les urines et d\u2019autres liquides biologiques (examen direct par RT-PCR), ou la s\u00e9rologie sur un pr\u00e9l\u00e8vement de sang (d\u00e9tection des anticorps sp\u00e9cifiques de la maladie Zika, IgM et IgG anti-Zika). La vir\u00e9mie et la virurie sont pr\u00e9coces et transitoire, les anticorps apparaissent secondairement IgM puis IgM (Fig. 1\n). La strat\u00e9gie diagnostique impose une recherche simultan\u00e9e d\u2019infection par les virus de la dengue, du chikungunya et Zika [32].",
            "cite_spans": [
                {
                    "start": 510,
                    "end": 514,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Diagnostic ::: Infection par le virus Zika",
            "ref_spans": [
                {
                    "start": 379,
                    "end": 385,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Deux points sont \u00e0 consid\u00e9rer :\u2022le risque d\u2019introduction de la maladie et de l\u2019impact \u00e9pid\u00e9mique possible en m\u00e9tropole, les conditions pour une transmission autochtone du virus Zika en m\u00e9tropole \u00e9tant r\u00e9unies, dans les d\u00e9partements o\u00f9 le moustique vecteur est pr\u00e9sent (A. albopictus, vecteur d\u00e9montr\u00e9 est implant\u00e9 en m\u00e9tropole depuis 2004 et s\u2019y \u00e9tend, la p\u00e9riode d\u2019activit\u00e9 s\u2019\u00e9tendant de mai \u00e0 novembre) ;\u2022le risque d\u2019infection chez le femme enceinte, et de transmission sexuelle de l\u2019homme \u00e0 la femme.\n",
            "cite_spans": [],
            "section": "Contr\u00f4le de la maladie ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "La strat\u00e9gie repose sur : (i) la surveillance des cas import\u00e9s et les cas group\u00e9s autochtone, (ii) le signalement des cas suspects d\u2019infection par le virus Zika \u00e0 la plateforme r\u00e9gionale de veille et d\u2019urgences sanitaires de l\u2019ARS, (iii) la prise en charge des patients en transposant les connaissances de la PEC du chikungunya y compris les mesures pour la pr\u00e9vention de la diss\u00e9mination \u00e0 l\u2019entourage (isolement de tout malade pr\u00e9sentant une maladie \u00e0 virus Zika suspect\u00e9e ou confirm\u00e9e pendant la p\u00e9riode f\u00e9brile sous moustiquaire ou dans un local avec fen\u00eatres ferm\u00e9es, afin d\u2019\u00e9viter la contamination de nouveaux moustiques vecteurs) [32], [43].",
            "cite_spans": [
                {
                    "start": 637,
                    "end": 641,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 643,
                    "end": 647,
                    "mention": "[43]",
                    "ref_id": "BIBREF42"
                }
            ],
            "section": "Contr\u00f4le de la maladie ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "Le dispositif de surveillance renforc\u00e9e du chikungunya et de la dengue mis en \u0153uvre chaque ann\u00e9e de mai \u00e0 novembre dans les d\u00e9partements o\u00f9 A. albopictus est implant\u00e9 fait partie int\u00e9grante du \u00ab Guide relatif aux modalit\u00e9s de mise en \u0153uvre du plan anti-diss\u00e9mination du chikungunya et de la dengue en m\u00e9tropole \u00bb pilot\u00e9 par le minist\u00e8re charg\u00e9 de la sant\u00e9.",
            "cite_spans": [],
            "section": "Contr\u00f4le de la maladie ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "De plus, les recommandations ont \u00e9t\u00e9 diffus\u00e9es dans le cadre de la pr\u00e9vention de la transmission sexuelle, de la pr\u00e9vention chez les femmes enceintes, les femmes ayant un projet de grossesse ou les femmes en \u00e2ge de procr\u00e9er, et chez les voyageurs se rendant dans une zone de circulation du Zika [42], [43], [44].",
            "cite_spans": [
                {
                    "start": 295,
                    "end": 299,
                    "mention": "[42]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 301,
                    "end": 305,
                    "mention": "[43]",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 307,
                    "end": 311,
                    "mention": "[44]",
                    "ref_id": "BIBREF43"
                }
            ],
            "section": "Contr\u00f4le de la maladie ::: Infection par le virus Zika",
            "ref_spans": []
        },
        {
            "text": "L\u2019infection se propage d\u2019homme \u00e0 homme :\u2022par contact direct avec tout fluide corporel de personnes infect\u00e9es (sang, larmes, salive, lait maternel, sperme, sueur, selles, vomissements) ;\u2022par exposition directe \u00e0 des objets contamin\u00e9s par les s\u00e9cr\u00e9tions de patients ;\u2022possiblement par voie a\u00e9roport\u00e9e notamment en cas d\u2019atteinte pulmonaire et de man\u0153uvres de soins g\u00e9n\u00e9rant des a\u00e9rosols, une transmission par voie a\u00e9rienne a \u00e9t\u00e9 document\u00e9e sur mod\u00e8les animaux [47].\n",
            "cite_spans": [
                {
                    "start": 458,
                    "end": 462,
                    "mention": "[47]",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "Transmission ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Les personnels de sant\u00e9 et de laboratoire sont particuli\u00e8rement \u00e0 risque.",
            "cite_spans": [],
            "section": "Transmission ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Un nombre infime de particules virales suffit pour infecter un individu.",
            "cite_spans": [],
            "section": "Transmission ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Un patient asymptomatique n\u2019est pas contagieux. Le d\u00e9but de la contagiosit\u00e9 est li\u00e9 \u00e0 la vir\u00e9mie et \u00e0 l\u2019apparition des premiers sympt\u00f4mes. Plus la maladie \u00e9volue, plus le patient est contagieux. La disparition des sympt\u00f4mes chez les survivants est corr\u00e9l\u00e9e \u00e0 la disparition du risque de contagion. Le cas du sperme est mieux document\u00e9 et des mesures de protection lors de rapports sexuels sont pr\u00e9conis\u00e9es durant quelques mois aux convalescents [47].",
            "cite_spans": [
                {
                    "start": 445,
                    "end": 449,
                    "mention": "[47]",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "Transmission ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Le temps d\u2019incubation est en moyenne de 8 jours (3 \u00e0 21 jours). Les signes sont peu sp\u00e9cifiques avant la phase h\u00e9morragique inconstante. Il existe des formes frustres et des infections inapparentes.",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Dans la forme habituelle, la maladie d\u00e9bute brutalement par un syndrome pseudo-grippal (fi\u00e8vre, myalgies, arthralgies, c\u00e9phal\u00e9es) et une profonde asth\u00e9nie psychomotrice. En 3\u20134 jours, apparaissent d\u2019autres signes cliniques cutan\u00e9o-muqueux (conjonctivite, exanth\u00e8me maculeux ou maculo-papuleux, dysphagie) et digestifs (diarrh\u00e9e, vomissements).",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "La phase terminale est marqu\u00e9e par des signes neurologiques d\u2019enc\u00e9phalite (de l\u2019obnubilation au coma, agitation, \u00e9pilepsie) et des signes h\u00e9morragiques (principalement saignements aux points de ponction, gingivorragies, h\u00e9mat\u00e9m\u00e8se, m\u00e9laena, selles sanglantes ; plus rarement \u00e9pistaxis, h\u00e9moptysie, h\u00e9morragie g\u00e9nitale ou h\u00e9matome). On peut observer plus inconstamment hoquet, paresth\u00e9sies, acouph\u00e8nes, trismus, h\u00e9patom\u00e9galie, spl\u00e9nom\u00e9galie, pancr\u00e9atite, uv\u00e9ite, parotidite, orchite, et douleur thoracique.",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Dans les formes h\u00e9morragiques, le d\u00e9c\u00e8s survient dans 80 % des cas en moyenne 8 jours apr\u00e8s l\u2019apparition de la fi\u00e8vre. Sinon la gu\u00e9rison est sans s\u00e9quelle mais la convalescence est longue avec une asth\u00e9nie prolong\u00e9e pendant plusieurs semaines et des arthralgies fluctuantes et migratrices.",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Les anomalies biologiques associent lymphop\u00e9nie initiale (3\u20135 premiers jours), suivie d\u2019une hyperleucocytose \u00e0 polynucl\u00e9aires neutrophiles, thrombop\u00e9nie, coagulation intravasculaire diss\u00e9min\u00e9e (CIVD), augmentation des transaminases (parfois consid\u00e9rable, portant plus sur les SGOT que les SGPT), de l\u2019amylase, de la bilirubine, et des LDH.",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Le manque de sp\u00e9cificit\u00e9 des signes cliniques, surtout \u00e0 la phase initiale, et l\u2019acc\u00e8s limit\u00e9 aux examens biologiques simples, n\u00e9cessitent de consid\u00e9rer de tr\u00e8s nombreuses pathologies tropicales end\u00e9miques (paludisme notamment) et maladies cosmopolites \u00e0 \u00e9voquer au retour de voyage en pays tropical [47].",
            "cite_spans": [
                {
                    "start": 300,
                    "end": 304,
                    "mention": "[47]",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Selon l\u2019Invs [48], un cas suspect est d\u00e9fini par toute personne pr\u00e9sentant, dans un d\u00e9lai de 21 jours apr\u00e8s son retour de la zone \u00e0 risque, une fi\u00e8vre sup\u00e9rieure ou \u00e9gale \u00e0 38,5 \u00b0C.",
            "cite_spans": [
                {
                    "start": 13,
                    "end": 17,
                    "mention": "[48]",
                    "ref_id": "BIBREF47"
                }
            ],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Un cas possible est d\u00e9fini (i) comme toute personne pr\u00e9sentant une fi\u00e8vre sup\u00e9rieure ou \u00e9gale \u00e0 38,5 \u00b0C et pour laquelle une exposition \u00e0 risque av\u00e9r\u00e9e a pu \u00eatre \u00e9tablie dans un d\u00e9lai de 21 jours avant le d\u00e9but des sympt\u00f4mes, ou (ii) qui pr\u00e9sente une forme clinique grave compatible avec une fi\u00e8vre h\u00e9morragique virale \u00e0 virus Ebola sans \u00e9valuation possible des expositions \u00e0 risque.",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Les expositions \u00e0 risque sont d\u00e9finies comme suit :\u2022contact avec le sang ou un autre fluide corporel d\u2019un patient infect\u00e9, ou suspect\u00e9 d\u2019\u00eatre infect\u00e9 par le virus Ebola ;\u2022contact direct avec une personne pr\u00e9sentant un syndrome h\u00e9morragique ou avec le corps d\u2019un d\u00e9funt, dans la zone \u00e0 risque ;\u2022travail dans un laboratoire qui d\u00e9tient des souches de virus Ebola ou des \u00e9chantillons contenant le virus Ebola ;\u2022travail dans un laboratoire qui d\u00e9tient des chauves-souris, des rongeurs ou des primates non humains originaires d\u2019une zone d\u2019\u00e9pid\u00e9mie d\u2019Ebola ;\u2022contact direct avec une chauve-souris, des rongeurs, des primates non humains ou d\u2019autres animaux sauvages dans la zone \u00e0 risque, ou en provenance de la zone \u00e0 risque ;\u2022manipulation ou consommation de viande issue de la chasse, crue ou peu cuite, dans la zone \u00e0 risque ;\u2022rapports sexuels avec un cas d\u2019Ebola confirm\u00e9, dans les 10 semaines suivant le d\u00e9but des sympt\u00f4mes du cas ;\u2022prise en charge pour une autre pathologie ou visite dans un h\u00f4pital ayant re\u00e7u des patients infect\u00e9s par le virus Ebola.\n",
            "cite_spans": [],
            "section": "Aspects cliniques [47]bib0235bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Le diagnostic de certitude repose sur la d\u00e9tection du mat\u00e9riel g\u00e9n\u00e9tique du virus Ebola par PCR : cette technique peut \u00eatre utilis\u00e9e d\u00e8s les premiers stades de l\u2019infection. Le risque rare d\u2019une n\u00e9gativit\u00e9 de la RT-PCR au d\u00e9but de la phase symptomatique, notamment chez les patients paucisymptomatiques, on ne peut exclure un cas sur la base d\u2019une RT-PCR n\u00e9gative dans les 48 heures suivant l\u2019apparition des sympt\u00f4mes.",
            "cite_spans": [],
            "section": "Diagnostic [49]bib0245bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Le d\u00e9ploiement de kits de diagnostic rapide par RT-PCR permet de r\u00e9duire le d\u00e9lai du diagnostic dans tous les ESRH. Une confirmation en urgence par le CNR est imp\u00e9rative en cas de positivit\u00e9.",
            "cite_spans": [],
            "section": "Diagnostic [49]bib0245bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "La d\u00e9tection des anticorps IgM ou IgG sp\u00e9cifiques par des m\u00e9thodes s\u00e9rologiques de type Elisa est beaucoup moins performante, et non utilisable dans un contexte d\u2019urgence.",
            "cite_spans": [],
            "section": "Diagnostic [49]bib0245bibr ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "La strat\u00e9gie a repos\u00e9 sur la surveillance, le classement des cas, la d\u00e9claration obligatoire des fi\u00e8vres h\u00e9morragiques africaines, et surtout l\u2019application stricte des pr\u00e9cautions d\u2019hygi\u00e8ne standard pour la prise en charge de tout patient, compl\u00e9t\u00e9es par les pr\u00e9cautions compl\u00e9mentaires de type \u00ab air \u00bb et \u00ab contact \u00bb avec mesures barri\u00e8res renforc\u00e9es pour tout patient suspect de MVE, et en cas de patient class\u00e9 possible ou confirm\u00e9, hospitalisation dans un dans un secteur adapt\u00e9, en chambre individuelle, avec sas, si possible \u00e0 pression n\u00e9gative, dans un des \u00e9tablissements de r\u00e9f\u00e9rence de la zone de d\u00e9fense (utilisation d\u2019appareil de protection respiratoire de type FFP2 voire de type FFP3 lors de soins \u00e0 risque \u00e9lev\u00e9 d\u2019a\u00e9rosolisation, utilisation d\u2019\u00e9quipement de protection individuel [EPI]), pr\u00e9cautions vis-\u00e0-vis des excr\u00e9ta (\u00e9limination dans la fili\u00e8re DASRI apr\u00e8s utilisation de produit solidifiant le cas \u00e9ch\u00e9ant et incin\u00e9ration obligatoire), \u00e9limination des DASRI selon un circuit sp\u00e9cifique, apr\u00e8s inactivation par eau de javel ou autoclavage, et incin\u00e9ration obligatoire.",
            "cite_spans": [],
            "section": "Contr\u00f4le de la maladie en France, vis-\u00e0-vis du risque de possibles cas import\u00e9s ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Enfin, le risque de r\u00e9surgence virale chez les patients consid\u00e9r\u00e9s comme gu\u00e9ris et la prise en charge de leurs contacts a \u00e9t\u00e9 pr\u00e9cis\u00e9e [50].",
            "cite_spans": [
                {
                    "start": 135,
                    "end": 139,
                    "mention": "[50]",
                    "ref_id": "BIBREF49"
                }
            ],
            "section": "Contr\u00f4le de la maladie en France, vis-\u00e0-vis du risque de possibles cas import\u00e9s ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "Les examens biologiques, limit\u00e9s \u00e0 ceux indispensables \u00e0 la prise en charge ou au diagnostic diff\u00e9rentiel n\u00e9cessitant un traitement dans un d\u00e9lai incompatible avec le diagnostic d\u2019\u00e9limination de FHV Ebola, sont r\u00e9serv\u00e9s obligatoirement \u00e0 un laboratoire de niveau de s\u00e9curit\u00e9 P3, dans un des \u00e9tablissements de r\u00e9f\u00e9rence zonal. Le transport des \u00e9chantillons au laboratoire ne peut se faire qu\u2019avec des syst\u00e8mes de transport s\u00e9curis\u00e9s (triple emballage r\u00e9pondant aux caract\u00e9ristiques de transport de classe A) et sans utilisation de l\u2019\u00e9ventuel pneumatique [49].",
            "cite_spans": [
                {
                    "start": 553,
                    "end": 557,
                    "mention": "[49]",
                    "ref_id": "BIBREF48"
                }
            ],
            "section": "Contr\u00f4le de la maladie en France, vis-\u00e0-vis du risque de possibles cas import\u00e9s ::: Maladie \u00e0 virus Ebola (MVE)",
            "ref_spans": []
        },
        {
            "text": "La transmission s\u2019effectue de personne \u00e0 personne par l\u2019interm\u00e9diaire de moustiques infect\u00e9s (Aedes). Le moustique s\u2019infecte lors d\u2019un repas sanguin sur d\u2019une personne infect\u00e9e. \u00c0 l\u2019issue d\u2019une phase de 10 jours environ, la transmission est possible \u00e0 une nouvelle personne \u00e0 l\u2019occasion d\u2019une piq\u00fbre par le moustique infect\u00e9.",
            "cite_spans": [],
            "section": "Transmission ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "Une personne infect\u00e9e est \u00ab contaminante pour les moustiques \u00bb pendant la phase vir\u00e9mique de l\u2019infection, soit de 1 \u00e0 2 jours environ avant le d\u00e9but des signes cliniques, jusqu\u2019\u00e0 7 jours apr\u00e8s [52].",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 197,
                    "mention": "[52]",
                    "ref_id": "BIBREF51"
                }
            ],
            "section": "Transmission ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "L\u2019incubation est de 4 \u00e0 7 jours (1\u201312 jours). Les signes associent une fi\u00e8vre \u00e9lev\u00e9e d\u2019apparition brutale accompagn\u00e9e d\u2019arthralgies pouvant \u00eatre intenses, touchant principalement les petites articulations des extr\u00e9mit\u00e9s (poignets, chevilles, phalanges), de myalgies, de c\u00e9phal\u00e9es, d\u2019une \u00e9ruption maculopapuleuse.",
            "cite_spans": [],
            "section": "Aspects cliniques [52]bib0260bibr ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "L\u2019\u00e9volution est le plus souvent favorable. L\u2019infection peut aussi \u00e9voluer vers une phase chronique marqu\u00e9e par des arthralgies persistantes.",
            "cite_spans": [],
            "section": "Aspects cliniques [52]bib0260bibr ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "Dans 5 \u00e0 25 % des cas l\u2019infection est asymptomatique.",
            "cite_spans": [],
            "section": "Aspects cliniques [52]bib0260bibr ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "Il repose sur la d\u00e9tection du virus ou de son g\u00e9nome ou la d\u00e9tection d\u2019anticorps (Fig. 2\n).",
            "cite_spans": [],
            "section": "Diagnostic biologique [52]bib0260bibr ::: Chikungunya",
            "ref_spans": [
                {
                    "start": 82,
                    "end": 88,
                    "mention": "Fig. 2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Un diagnostic pr\u00e9coce (dans la semaine qui suit le d\u00e9but des sympt\u00f4mes) peut \u00eatre obtenu par amplification g\u00e9nique (RT-PCR). Les IgM peuvent \u00eatre identifi\u00e9es \u00e0 partir du cinqui\u00e8me jour apr\u00e8s l\u2019apparition des signes cliniques et persistent en moyenne 2 \u00e0 3 mois. Les IgG apparaissent quelques jours apr\u00e8s les IgM et persistent toute la vie.",
            "cite_spans": [],
            "section": "Diagnostic biologique [52]bib0260bibr ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "Ainsi, la d\u00e9marche diagnostique recommand\u00e9e est la suivante :\u2022jusqu\u2019\u00e0 5 jours apr\u00e8s le d\u00e9but des signes (j5) : RT-PCR ;\u2022entre j5 et j7 : RT-PCR et s\u00e9rologie ;\u2022apr\u00e8s j7 : s\u00e9rologie uniquement (IgG et IgM) avec un second pr\u00e9l\u00e8vement de confirmation au plus t\u00f4t 10 jours apr\u00e8s le premier pr\u00e9l\u00e8vement.\n",
            "cite_spans": [],
            "section": "Diagnostic biologique [52]bib0260bibr ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "La pr\u00e9vention individuelle repose essentiellement sur les moyens de protection contre les piq\u00fbres de moustiques (r\u00e9pulsifs en sprays ou cr\u00e8mes, serpentins, diffuseurs \u00e9lectriques, v\u00eatements longs, moustiquaires). Le moustique vecteur pique la journ\u00e9e, essentiellement \u00e0 l\u2019ext\u00e9rieur des maisons, avec une activit\u00e9 plus importante en d\u00e9but de matin\u00e9e et en fin de journ\u00e9e [52].",
            "cite_spans": [
                {
                    "start": 370,
                    "end": 374,
                    "mention": "[52]",
                    "ref_id": "BIBREF51"
                }
            ],
            "section": "Contr\u00f4le de la maladie ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "Les mesures de lutte contre les moustiques utilisables pour pr\u00e9venir la diffusion du chikungunya en France m\u00e9tropolitaine repose sur (i) la lutte antivectorielle \u00e0 l\u2019\u00e9chelle de territoires, r\u00e9alis\u00e9e par des op\u00e9rateurs publics de d\u00e9moustication, (ii) la lutte communautaire, de la responsabilit\u00e9 de tous, r\u00e9alis\u00e9e par la destruction des g\u00eetes larvaires potentiels autour des habitations (eau stagnante dans les soucoupes, goutti\u00e8res, vases, seaux, d\u00e9tritus\u2026) pour priver les moustiques des sites o\u00f9 leurs larves peuvent se d\u00e9velopper, (iii) la protection individuelle contre les piq\u00fbres de moustique [53], [54], [55].",
            "cite_spans": [
                {
                    "start": 599,
                    "end": 603,
                    "mention": "[53]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 605,
                    "end": 609,
                    "mention": "[54]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 611,
                    "end": 615,
                    "mention": "[55]",
                    "ref_id": "BIBREF54"
                }
            ],
            "section": "Contr\u00f4le de la maladie ::: Chikungunya",
            "ref_spans": []
        },
        {
            "text": "Les MIE ou r\u00e9-\u00e9mergentes survenues au cours des derni\u00e8res d\u00e9cades posent des probl\u00e8mes diff\u00e9rents, selon la virulence de l\u2019agent infectieux, la mortalit\u00e9 imput\u00e9e, les modalit\u00e9s de transmission, l\u2019impact sur la transmission maternof\u0153tale (Zika).",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "Chaque praticien doit \u00eatre conscient de possibles \u00e9mergences, savoir rep\u00e9rer une pathologie inhabituelle, et savoir appliquer les plans et des recommandations \u00e9tablis par les autorit\u00e9s de tutelle, de mani\u00e8re \u00e0 identifier le plus vite possible tout cas de maladie infectieuse \u00e9mergente hautement transmissible virulente pour isolement imm\u00e9diat et prise en charge ad\u00e9quate.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "Les auteurs d\u00e9clarent ne pas avoir de liens d\u2019int\u00e9r\u00eats.",
            "cite_spans": [],
            "section": "D\u00e9claration de liens d\u2019int\u00e9r\u00eats",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Tableau 1: SRAS : pr\u00e9sentation clinique (%).\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Tableau 2: SRAS : signes biologiques (%).\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Tableau 3: Grippe humaine A(H5N1) : caract\u00e9ristiques des patients, pr\u00e9sentation clinique et \u00e9volution.\n",
            "type": "table"
        },
        "TABREF3": {
            "text": "Tableau 4: Manifestations cliniques chez 47 cas de MERS-CoV (Arabie saoudite).\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Fig. 1: Cin\u00e9tique du virus et des anticorps au cours de l\u2019infection par le virus Zika.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig. 2: Cin\u00e9tique du virus et des anticorps au cours d\u2019une infection par le virus du chikungunya.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Obituary: William H Stewart",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Bristol",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Lancet",
            "volume": "372",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "HCSP",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Les maladies infectieuses \u00e9mergentes\u00a0: \u00e9tat de la situation et perspectives. La documentation fran\u00e7aise",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "\u00c6tiology: Koch's postulates fulfilled for SARS virus",
            "authors": [
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Fouchier",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Kuiken",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Schutten",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "van Amerongen",
                    "suffix": ""
                },
                {
                    "first": "G.J.",
                    "middle": [],
                    "last": "van Doornum",
                    "suffix": ""
                },
                {
                    "first": "B.G.",
                    "middle": [],
                    "last": "van den Hoogen",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nature",
            "volume": "423",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Kuiken",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Fouchier",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Schutten",
                    "suffix": ""
                },
                {
                    "first": "G.F.",
                    "middle": [],
                    "last": "Rimmelzwaan",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "van Amerongen",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "van Riel",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "362",
            "issn": "",
            "pages": "263-270",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Epidemiological determinants of spread of causal agent of Severe Acute Respiratory Syndrome in Hong Kong",
            "authors": [
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Donnelly",
                    "suffix": ""
                },
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Ghani",
                    "suffix": ""
                },
                {
                    "first": "G.M.",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "A.J.",
                    "middle": [],
                    "last": "Hedley",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Fraser",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Riley",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1761-1766",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "SARS transmission among hospital workers in Hong Kong",
            "authors": [
                {
                    "first": "J.T.",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "K.S.",
                    "middle": [],
                    "last": "Fung",
                    "suffix": ""
                },
                {
                    "first": "T.W.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Emerg Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "280-286",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "SARS in three categories of hospital workers, Hong Kong",
            "authors": [
                {
                    "first": "J.T.",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "P.C.",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Fong",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Emerg Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "1399-1404",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "CMIT",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "EPilly 2016",
            "volume": "",
            "issn": "",
            "pages": "423-425",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Mc Intosh",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Perlmann",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Mandell, Douglas, and Bennett's Principles and Practices in Infectious Diseases",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "WHO",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Probable person-to-person transmission of avian influenza A (H5N1)",
            "authors": [
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Ungchusak",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Auewarakul",
                    "suffix": ""
                },
                {
                    "first": "S.F.",
                    "middle": [],
                    "last": "Dowell",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Kitphati",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Auwanit",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Puthavathana",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "N Engl J Med",
            "volume": "352",
            "issn": "",
            "pages": "333-340",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "WHO",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Middle East respiratory syndrome",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Zumla",
                    "suffix": ""
                },
                {
                    "first": "D.S.",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet",
            "volume": "386",
            "issn": "",
            "pages": "995-1007",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Middle East respiratory syndrome coronavirus: update for clinicians",
            "authors": [
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "S.I.",
                    "middle": [],
                    "last": "Gerber",
                    "suffix": ""
                },
                {
                    "first": "D.L.",
                    "middle": [],
                    "last": "Swerdlow",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Clin Infect Dis",
            "volume": "60",
            "issn": "",
            "pages": "1686-1689",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Middle East respiratory syndrome coronavirus: implications for health care facilities",
            "authors": [
                {
                    "first": "H.C.",
                    "middle": [],
                    "last": "Maltezou",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Tsiodras",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Am J Infect Control",
            "volume": "42",
            "issn": "",
            "pages": "1261-1265",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Hospital-associated outbreak of Middle East Respiratory Syndrome coronavirus: a serologic, epidemiologic, and clinical description",
            "authors": [
                {
                    "first": "M.M.",
                    "middle": [],
                    "last": "Al-Abdallat",
                    "suffix": ""
                },
                {
                    "first": "D.C.",
                    "middle": [],
                    "last": "Payne",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Alqasrawi",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Rha",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Tohme",
                    "suffix": ""
                },
                {
                    "first": "G.R.",
                    "middle": [],
                    "last": "Abedi",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Clin Infect Dis",
            "volume": "59",
            "issn": "",
            "pages": "1225-1233",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Middle East respiratory syndrome coronavirus in healthcare settings",
            "authors": [
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Al-Tawfiq",
                    "suffix": ""
                },
                {
                    "first": "T.M.",
                    "middle": [],
                    "last": "Perl",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Curr Opin Infect Dis",
            "volume": "28",
            "issn": "",
            "pages": "392-396",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Epidemiologic investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015",
            "authors": [
                {
                    "first": "H.Y.",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "E.J.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "Y.W.",
                    "middle": [],
                    "last": "Ryu",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "S.J.",
                    "middle": [],
                    "last": "Yi",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Euro Surveill",
            "volume": "20",
            "issn": "",
            "pages": "1-6",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "2014\u00a0MERS-CoV outbreak in Jeddah \u2013 a link to health care facilities",
            "authors": [
                {
                    "first": "I.K.",
                    "middle": [],
                    "last": "Oboho",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Tomczyk",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Al-Asmari",
                    "suffix": ""
                },
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Banjar",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "AL-Mugti",
                    "suffix": ""
                },
                {
                    "first": "M.S.",
                    "middle": [],
                    "last": "Aloraini",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "New Engl J Med",
            "volume": "372",
            "issn": "",
            "pages": "846-854",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Emerging infectious diseases: focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)",
            "authors": [
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Weber",
                    "suffix": ""
                },
                {
                    "first": "W.A.",
                    "middle": [],
                    "last": "Rutala",
                    "suffix": ""
                },
                {
                    "first": "W.A.",
                    "middle": [],
                    "last": "Fischer",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Kanamori",
                    "suffix": ""
                },
                {
                    "first": "E.E.",
                    "middle": [],
                    "last": "Sickbert-bennett",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Am J Infect Control",
            "volume": "44",
            "issn": "",
            "pages": "e91-e100",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "HCSP",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Invs",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "InV.S.",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Probable non-vector-borne transmission of zika virus, Colorado, USA",
            "authors": [
                {
                    "first": "B.D.",
                    "middle": [],
                    "last": "Foy",
                    "suffix": ""
                },
                {
                    "first": "K.C.",
                    "middle": [],
                    "last": "Kobylinski",
                    "suffix": ""
                },
                {
                    "first": "J.L.",
                    "middle": [],
                    "last": "Chilson Foy",
                    "suffix": ""
                },
                {
                    "first": "B.J.",
                    "middle": [],
                    "last": "Blitvich",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Travassos da Rosa",
                    "suffix": ""
                },
                {
                    "first": "A.D.",
                    "middle": [],
                    "last": "Haddow",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Emerg Infect Dis",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Suspected female-to-male sexual transmission of Zika virus\u2014New York City, 2016",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Davidson",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Slavinski",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Komoto",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Rakeman",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "65",
            "issn": "",
            "pages": "716-717",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "World Health Organization",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Late sexual transmission of Zika virus related to persistence in the semen",
            "authors": [
                {
                    "first": "J.M.",
                    "middle": [],
                    "last": "Turmel",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Abgueguen",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Hubert",
                    "suffix": ""
                },
                {
                    "first": "Y.M.",
                    "middle": [],
                    "last": "Vandamme",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Maquart",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Le Guillou-Guillemette",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Lancet",
            "volume": "387",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Zika virus in semen of a patient returning from a non-epidemic area",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Mansuy",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Pasquier",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Daudin",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Chapuy-Regaud",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Moinard",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Chevreau",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Lancet Infect Dis",
            "volume": "16",
            "issn": "",
            "pages": "894-895",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Zika virus in the female genital tract",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Prisant",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Bujan",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Benichou",
                    "suffix": ""
                },
                {
                    "first": "P.H.J.",
                    "middle": [],
                    "last": "Hayot",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Pavili",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Lurel",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Lancet Infect Dis",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "",
            "authors": [],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "Evidence of perinatal transmission of zika virus, French Polynesia, December 2013\u00a0and February 2014",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Besnard",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Lastere",
                    "suffix": ""
                },
                {
                    "first": "V.M.",
                    "middle": [],
                    "last": "Cao-Lormeau",
                    "suffix": ""
                },
                {
                    "first": "L.M.D.",
                    "middle": [],
                    "last": "Musso",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Euro Surveill",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "HCSP",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "WHO",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "HCSP",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "HCSP",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "HCSP",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "",
            "authors": [],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF54": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF55": {
            "title": "A major outbreak of severe acute respiratory syndrome in Hong Kong",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Cameron",
                    "suffix": ""
                },
                {
                    "first": "G.M.",
                    "middle": [],
                    "last": "Joynt",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "1986-1994",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Coronavirus as a possible cause of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "J.S.",
                    "middle": [],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "S.T.",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "L.L.",
                    "middle": [],
                    "last": "Poon",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "L.Y.",
                    "middle": [],
                    "last": "Yam",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1319-1325",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong",
            "authors": [
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Donnelly",
                    "suffix": ""
                },
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Ghani",
                    "suffix": ""
                },
                {
                    "first": "G.M.",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "A.J.",
                    "middle": [],
                    "last": "Hedley",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Fraser",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Riley",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1761-1766",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "Avian influenza A (H5N1) infection in humans",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "N Engl J Med",
            "volume": "353",
            "issn": "",
            "pages": "1374-1385",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF59": {
            "title": "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Assiri",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Jaff ar",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Al-Tawfi",
                    "suffix": ""
                },
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Al-Rabeeah",
                    "suffix": ""
                },
                {
                    "first": "F.A.",
                    "middle": [],
                    "last": "Al-Rabiah",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Al-Hajjar",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Lancet Infect Dis",
            "volume": "13",
            "issn": "",
            "pages": "752-761",
            "other_ids": {
                "DOI": []
            }
        }
    }
}